Surfactant abnormalities after single lung transplantation in dogs: impact of bronchoscopic surfactant administration  Andreas Günther, MD, Markus Balser,

Slides:



Advertisements
Similar presentations
Effect of inhaled tacrolimus on ischemia reperfusion injury in rat lung transplant model Johanna Bayer, MD, Nitin A. Das, MD, Clinton E. Baisden, MD, Meenakshi.
Advertisements

Manuel J. Antunes, MD, PhD, DSc 
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Lobar lung transplantation: One size fits all
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,
Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 
Influence of oxygen in inflation gas during lung ischemia on ischemia-reperfusion injury  Atsushi Watanabe, MD, Nobuyoshi Kawaharada, MD, Katsuyuki Kusajima,
Building a bioartificial heart: A 3-song saga
M. Griese, MD, C. Wilnhammer, MD, S. Jansen *, C. Rinker, MD 
Ground glass opacity of the lung: The veil that needs lifting
Right internal thoracic artery or saphenous vein grafting
Ex vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death  Cynthia E. Wagner,
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Glutathione improves the function of porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution  Sebastian-P. Sommer, MD,
Surfactant function in lung transplantation after 24 hours of ischemia: Advantage of retrograde flush perfusion for preservation  Martin Strüber, MDa,
Surfactant Improves Graft Function After Gastric Acid–Induced Lung Damage in Lung Transplantation  Ilhan Inci, MD, Sven Hillinger, MD, Stephan Arni, PhD,
William M. DeCampli, MD, PhD 
Multilevel data analysis: What? Why? How?
Marye J. Gleva, MD, Charles B. Huddleston, MD 
How should we treat air leaks?
Bigger The Journal of Thoracic and Cardiovascular Surgery
The lord of the rings  Antonio Miceli, MD, PhD 
Is tissue the issue?  Brian E. Louie, MD, MHA, MPH, FRCSC, FACS 
Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery  Pedro J.
Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model  Daniel.
Richard J. Novick, MDa, Ruud A. W
Yang Zhang, MD, Haiquan Chen, MD, PhD 
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Seeing a tree through the forest: Precision medicine tools can enhance donor allocation in heart transplantation  Vishnu Vasanthan, MD, Paul W.M. Fedak,
Support Your Specialty
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Bartley P. Griffith, MD, FACS, FRCS 
Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function  Martin Strüber, MDa, Jens M. Hohlfeld, MDb,
Military surgeons just want to have fun
Experience from an American Association for Thoracic Surgery Foundation for Thoracic Surgery Training Fellowship: Lung transplantation in Toronto General.
A first start for lung transplantation?
Ashok Muniappan, MD  The Journal of Thoracic and Cardiovascular Surgery 
Validating the use of short interfering RNA as a novel technique for cell-specific target gene knockdown in lung ischemia–reperfusion injury  Heather.
Torsten Doenst, MD, PhD, Markus Richter, MD 
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Richard J. Novick, MDa, Andrea A. Gilpin, MSca,b, Kenneth E
Impact of low donor to recipient weight ratios on cardiac transplantation  Senthil Nathan Jayarajan, MD, Sharven Taghavi, MD, Eugene Komaroff, PhD, Abeel.
Jason M. Gauthier, MD, Ruben G. Nava, MD, Daniel Kreisel, MD, PhD 
Daniel Kreisel, MD, PhD, Alexander S
The Ross procedure: Time to reevaluate the guidelines
Video-assisted resection for lung cancer results in fewer complications  Lunxu Liu, PhD, MD, FRCS  The Journal of Thoracic and Cardiovascular Surgery 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
The thoracoabdominal saga and heroes
Sutureless valve implantation: Every detail counts
How much does early fundoplication for lung transplant recipients with gastroesophageal reflux disease truly help? Challenges in escaping the perils of.
Johanna Bayer, MD, Nitin A. Das, MD, Clinton E
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Bicuspid aortopathy: Seeing the forest for the trees
“The more things change…”: The challenges ahead
Toward a more rational approach in treating type B aortic dissection
Iloprost to improve surfactant function in porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution  Bernhard Gohrbandt,
Toll-like receptor 4 inhibition attenuates ischemia-reperfusion injury in rats: Will it work in human beings?  Chadrick E. Denlinger, MD  The Journal.
Apples remain apples NO matter what
Who should decide margin length in pulmonary excision of lung cancer?
Did you like Terminator 3 better than Terminator 2
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
A good chimney requires a good sweep
How do we follow up our patients
Journal changes and initiatives
Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks!  W. Hampton Gray, MD, P. Michael.
Calpain inhibitors: The aspirin of the 21st century?
Presentation transcript:

Surfactant abnormalities after single lung transplantation in dogs: impact of bronchoscopic surfactant administration  Andreas Günther, MD, Markus Balser, MD, Reinhold Schmidt, PhD, Philipp Markart, MD, Alexander Olk, MD, Jochen Börgermann, MD, Fred H Splittgerber, MD, Werner Seeger, MD, Ivar Friedrich, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 127, Issue 2, Pages 344-354 (February 2004) DOI: 10.1016/j.jtcvs.2002.09.001

Figure 1 Relative amount (in percent of all phosphatidylcholine molecular species, left panel) and absolute concentration (right panel) of dipalmitoylated phosphatidylcholine (DPPC) molecular species from BALF of treated and untreated grafts and native lungs during reperfusion over 12 hours. Depicted are the mean ± SEM of 6 independent experiments. *P < .05, **P < .01, comparison between untreated and treated organs. The 0-hour values of the native lung represent the baseline values (excised lung from the recipient) and the 0-hour values of the graft represent the postischemia values (obtained by bronchoalveolar lavage [BAL] of the nontransplanted lung at the end of the ischemia period). The Journal of Thoracic and Cardiovascular Surgery 2004 127, 344-354DOI: (10.1016/j.jtcvs.2002.09.001)

Figure 2 Minimum surface tension of large surfactant aggregates in absence (left panel) and in presence of proteins (right panel) from treated and untreated grafts and native lungs during reperfusion over 12 hours. Depicted are the mean ± SEM of 6 independent experiments. Reconstitution with bronchoalveolar lavage–derived proteins was performed as detailed in the Methods section. Surface activity was assessed in the Pulsating Bubble Surfactometer at 2 mg/mL phospholipid always. *P < .05, ***P < .001, comparison between untreated and treated organs; ++P < .01), +++P < .001, comparison between baseline and the untreated donor lung. The 0-hour values of the native lung represent the baseline values (excised lung from the recipient) and the 0-hour values of the graft represent the postischemia values (obtained by BAL of the nontransplanted lung at the end of the ischemia period). The Journal of Thoracic and Cardiovascular Surgery 2004 127, 344-354DOI: (10.1016/j.jtcvs.2002.09.001)

Figure 3 Correlation of all data sets of relative palmitic acid concentration in PC and minimum surface tension, as assessed in the non–surfactant-treated lungs. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 344-354DOI: (10.1016/j.jtcvs.2002.09.001)